Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPV1 | Q8NER1 | 9/20 | 0.64 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.56 |
| ▸ | CNR2 | P34972 | 1/20 | 0.46 |
| ▸ | METAP2 | P50579 | 1/20 | 0.43 |
| ▸ | NOS3 | P29474 | 1/20 | 0.42 |
| ▸ | NOS1 | P29475 | 1/20 | 0.42 |
| ▸ | NOS2 | P35228 | 1/20 | 0.42 |
| ▸ | NPC1 | O15118 | 3/20 | 0.41 |
| ▸ | RAB9A | P51151 | 3/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | HPGD | P15428 | 2/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2477267 | 0.83 | TRPV1 (0.62) | TRPV1CYP2A6CNR2METAP2NOS3 | |
| SCHEMBL22921169 | 0.82 | CYP2A6 (0.55) | TRPV1CYP2A6CNR2METAP2NOS3 | |
| SCHEMBL13834139 | 0.82 | CYP2A6 (0.63) | TRPV1CYP2A6CNR2METAP2NOS3 | |
| SCHEMBL64623 | 0.81 | CYP2A6 (0.68) | TRPV1CYP2A6CNR2METAP2NOS3 | |
| SCHEMBL32509667 | 0.81 | CYP2A6 (0.68) | TRPV1CYP2A6CNR2METAP2NOS3 | |
| SCHEMBL12817334 | 0.81 | CYP2A6 (0.62) | TRPV1CYP2A6CNR2METAP2NOS3 | |
| SCHEMBL10094698 | 0.80 | TRPV1 (0.64) | TRPV1CYP2A6CNR2METAP2NOS3 | |
| SCHEMBL3974637 | 0.80 | CYP2A6 (0.56) | TRPV1CYP2A6CNR2METAP2NOS3 | |
| SCHEMBL3975427 | 0.80 | CYP2A6 (0.56) | TRPV1CYP2A6CNR2METAP2NOS3 | |
| SCHEMBL1259263 | 0.80 | CYP2A6 (0.56) | TRPV1CYP2A6CNR2METAP2NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9722191-B2 | Organic light-emitting device | SAMSUNG DISPLAY CO., LTD. (KR) | 2017-08-01 | — | — | US | disclosed |
| US-9722191-B2 | Organic light-emitting device | SAMSUNG DISPLAY CO., LTD. (KR) | 2017-08-01 | — | — | US | disclosed |
| US-9478750-B2 | Anthracene derivative and organic electroluminescent element using the same | JNC CORPORATION (JP) | 2016-10-25 | — | — | US | disclosed |
| CN-103958471-B | Anthracene derivant and use its organic electric field luminescence assembly, electron transport material, display device and lighting device | 捷恩智株式会社 | 2016-08-17 | — | — | CN | disclosed |
| US-20160043330-A1 | ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2016-02-11 | — | — | US | disclosed |
| US-20160043330-A1 | ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2016-02-11 | — | — | US | disclosed |
| US-20150060808-A1 | INDENOPYRIDINE-BASED COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SUNGKYUNKWAN UNIVERSITY FOUNDATION FOR CORPORATE COLLABORATION (KR) | 2015-03-05 | — | — | US | disclosed |
| US-20150060808-A1 | INDENOPYRIDINE-BASED COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SUNGKYUNKWAN UNIVERSITY FOUNDATION FOR CORPORATE COLLABORATION (KR) | 2015-03-05 | — | — | US | disclosed |
| CN-103958471-A | Anthracene derivative and organic electroluminescent element using same | JNC CORP | 2014-07-30 | — | — | CN | disclosed |
| US-8541572-B2 | Compounds for the treatment of inflammatory disorders | MERCK SHARP & DOHME CORP. (US) | 2013-09-24 | — | — | US | disclosed |
| US-20120010181-A1 | COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS | MERCK SHARP & DOHME CORP. | 2012-01-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120010181-A1 | COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS | TNF, ADAMTS1, ADAMTS7 | TRPV1 1034/4885CYP2A6 991/4885CNR2 1515/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.